Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective

被引:117
|
作者
de Joode, K. [1 ,2 ]
Dumoulin, D. W. [3 ]
Engelen, V. [4 ]
Bloemendal, H. J. [5 ]
Verheij, M. [6 ,7 ]
van Laarhoven, H. W. M. [8 ]
Dingemans, I. H. [4 ]
Dingemans, A. C. [3 ,9 ]
van der Veldt, A. A. M. [1 ,2 ]
机构
[1] Erasmus MC, Canc Inst, Dept Med Oncol, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[3] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands
[4] Dutch Federat Canc Patient Org, Utrecht, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Nijmegen, Netherlands
[6] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[8] Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[9] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, Dept Pulm Dis GROW, Maastricht, Netherlands
关键词
Coronavirus; COVID-19; Pandemic; Cancer; Patients' perspective; LUNG-CANCER;
D O I
10.1016/j.ejca.2020.06.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has inevitable consequences for medical care of patients without COVID-19. To assess the impact of this pandemic on oncological care, a nationwide survey was conducted among patients with cancer in the Netherlands. Methods: The patients' perspective on oncological care was investigated using an online survey between March 29th 2020 and April 18th 2020. The survey consisted of 20 questions on four topics: patients' characteristics, contact with the hospital, consequences of the COVID-19 pandemic and concerns about COVID-19. Results: Five thousand three hundred two patients with cancer completed this nationwide survey. Overall, 30% of patients reported consequences for their oncological treatment or follow-up. In the majority of cases, this resulted in conversion from hospital visit to consultation by phone or video. The most frequently adjusted treatments were chemotherapy (30%) and immunotherapy (32%). Among patients with delay and discontinuation of treatment, 55% and 63% of patients, respectively, were (very) concerned about these consequences of the COVID-19 pandemic. Consequences were independent of regional differences in COVID-19 incidence. However, patients in regions with high COVID-19 incidence were significantly more concerned. Conclusion: This is the first study investigating perspectives of patients with cancer during the COVID-19 pandemic. The study demonstrates the significant impact of the COVID-19 crisis on oncological care, indicating the need for psycho-oncological support during this pandemic. (C) 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:132 / 139
页数:8
相关论文
共 50 条
  • [31] Changes in Treatment of Patients with Incident ESKD during the Novel Coronavirus Disease 2019 Pandemic
    Wetmore, James B.
    Johansen, Kirsten L.
    Liu, Jiannong
    Peng, Yi
    Gilbertson, David T.
    Weinhandl, Eric D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (11): : 2948 - 2957
  • [32] Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic
    Indini, Alice
    Rijavec, Erika
    Ghidini, Michele
    Cattaneo, Monica
    Grossi, Francesco
    EUROPEAN JOURNAL OF CANCER, 2020, 135 : 47 - 50
  • [33] Acute stroke treatment during coronavirus disease 2019 pandemic
    Baracchini, Claudio
    Pieroni, Alessio
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (01) : 11 - 17
  • [34] Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China
    Si Yi-Ran
    Du Feng
    Hu Nan-Lin
    Wang Xue
    Yue Jian
    Jiang Pei-Di
    Xu Bing-He
    Yuan Peng
    中华医学杂志英文版, 2021, 134 (05) : 590 - 592
  • [35] Clinical outcomes of obstructive colorectal cancer patients during the coronavirus disease 2019 pandemic
    Kulle, Cemil Burak
    Sengun, Berke
    Gok, Ali Fuat Kaan
    Ozgur, Ilker
    Bayraktar, Adem
    Ertekin, Cemalettin
    Deniz, Alisan Berk
    Keskin, Metin
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2023, 29 (06): : 663 - 668
  • [36] Managing Lung Cancer during Coronavirus Disease 2019 Pandemic
    Khalifeh, Yara Ibrahim
    Tfayli, Arafat Hussein
    TURKISH THORACIC JOURNAL, 2021, 22 (02): : 163 - 168
  • [37] Ultraviolet diagnostic and treatment modalities in the coronavirus disease 2019 pandemic
    Dourmishev, Lyubomir
    Guleva, Dimitrina
    CLINICS IN DERMATOLOGY, 2021, 39 (03) : 446 - 450
  • [38] The Coronavirus Disease 2019 Global Pandemic: A Neurosurgical Treatment Algorithm
    Burke, John F.
    Chan, Andrew K.
    Mummaneni, Valli
    Chou, Dean
    Lobo, Errol P.
    Berger, Mitchel S.
    Theodosopoulos, Philip
    Mummaneni, Praveen V.
    NEUROSURGERY, 2020, 87 (03) : E407 - E407
  • [39] Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan
    Fujita, Shohei
    Sakuramoto, Shinichi
    Miyawaki, Yutaka
    Morimoto, Yosuke
    Ebara, Gen
    Nishibeppu, Keiji
    Oya, Shuichiro
    Fujihata, Shiro
    Lee, Seigi
    Sugita, Hirofumi
    Sato, Hiroshi
    Yamashita, Keishi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 930 - 939
  • [40] Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan
    Shohei Fujita
    Shinichi Sakuramoto
    Yutaka Miyawaki
    Yosuke Morimoto
    Gen Ebara
    Keiji Nishibeppu
    Shuichiro Oya
    Shiro Fujihata
    Seigi Lee
    Hirofumi Sugita
    Hiroshi Sato
    Keishi Yamashita
    International Journal of Clinical Oncology, 2022, 27 : 930 - 939